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To a large extent, signaling processes 
between neurons in the brain are distinct 
from signaling mechanisms between 
cells in the immune system and use 
different signaling molecules. However, 
some proteins first discovered within 
the immune system act as both periph-
eral immune-signaling molecules and 
brain-signaling molecules. These 
neuroimmune factors include various 
cytokines, Toll-like receptors (TLRs), 
and high-mobility group protein box 1 
(HMGB1). In the brain, both neurons 
and supporting glial cells (both astro-
cytes and microglia) contribute to the 
release of and responses to these 
neuroimmune factors. Neuroimmune 
signaling in the brain not only is a part 
of the innate immune response, but its 
effects also persist for long periods and 
could contribute to long-lasting 
changes in neurobiology.
Studies found that brain neuroim-
mune signaling is activated in models 
of binge drinking and neurodegenera-
tion, suggesting another pathway 
through which alcohol may affect 
brain function. This review defines the 
roles of various cellular compartments 
and signaling molecules involved in 
neuroimmune activation, including 
the role of the stress axis in the 
communication between the central 
and peripheral immune systems and in 
sensitizing the neuroimmune response 
to alcohol. The article also will offer 
evidence from animal studies and 
postmortem human alcoholic brain 
studies that neuroimmune signaling 
may increase alcohol drinking and 
risky decision making and (in alcohol- 
treated animals) blunt the ability  
to change, decreasing behavioral 
flexibility. 
Neuroimmune Signaling  
in the Alcoholic Brain
Monocytes and Innate  
Immune Genes
Innate immune genes are associated 
with rapid first-line responses to infec-
tions that involve primarily immune 
cells called monocytes (e.g., the acute-
Induction of neuroimmune genes by binge drinking increases neuronal excitability and 
oxidative stress, contributing to the neurobiology of alcohol dependence and causing 
neurodegeneration. Ethanol exposure activates signaling pathways featuring high- 
mobility group box 1 and Toll-like receptor 4 (TLR4), resulting in induction of the tran-
scription factor nuclear factor kappa-light-chain-enhancer of activated B cells, which 
regulates expression of several cytokine genes involved in innate immunity, and its 
target genes. This leads to persistent neuroimmune responses to ethanol that stimulate 
TLRs and/or certain glutamate receptors (i.e., N-methyl-d-aspartate receptors). Alcohol 
also alters stress responses, causing elevation of peripheral cytokines, which further 
sensitize neuroimmune responses to ethanol. Neuroimmune signaling and glutamate 
excitotoxicity are linked to alcoholic neurodegeneration. Models of alcohol abuse have 
identified significant frontal cortical degeneration and loss of hippocampal neurogenesis, 
consistent with neuroimmune activation pathology contributing to these alcohol- 
induced, long-lasting changes in the brain. These alcohol-induced long-lasting increases 
in brain neuroimmune-gene expression also may contribute to the neuro- 
biology of alcohol use disorder. 
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phase response). These responses include 
increases in multiple cytokines as well 
as in their cellular receptors. Together, 
these changes amplify expression of a 
large number of genes through kinase 
signaling pathways that converge on 
two transcription factors called nuclear 
factor kappa-light-chain-enhancer of 
activated B cells (NF-κB) and activa-
tor protein-1 (AP-1). NF-κB and 
AP-1 promote expression of innate 
immune cytokines, such as tumor 
necrosis factor alpha (TNF-α) and 
interleukin 1 beta (IL-1β), as well as 
of TLRs and cytokine receptors (see 
figure 1). In addition, innate immune 
responses include the activation of 
proteases and oxidases, particularly 
cyclooxygenase and nicotinamide 
adenine dinucleotide phosphate 
(NADPH) oxidase,1 as well as of 
major histocompatibility complex 
(MHC) signaling molecules, such as 
beta-2 microglobulin. 
Figure 1   Simplified schematic of the Toll-like receptor (TLR) and the receptor for advanced glycation end products (RAGE) signaling cascades. 
Stimulation of TLRs with high-mobility group box 1 protein (HMGB1) and other inflammation-inducing agents leads to the generation of  
reactive oxygen species (ROS) and downstream activation of the transcription factor nuclear factor kappa-light-chain-enhancer of activated B 
cells (NF)-κB. Similarly, HMGB1 activation of the RAGE receptor results in downstream activation of NF-κB and induction of ROS. Transfer of 
NF-κB to the nucleus induces proinflammatory gene expression, neuroimmune induction, and cell death. Expression of several TLRs (i.e., 
TLR2, TLR3, and TLR4) and HMGB1 is upregulated in the postmortem human alcoholic brain and mouse brain following exposure to ethanol 
(Crews et al. 2013); this is accompanied by an upregulation of NADPH oxidase expression (Qin et al. 2011). Interestingly, blockade of 
neuroimmune signaling, either genetically (Blanco 2005) or pharmacologically (Crews et al. 2006b; Qin et al. 2012; Zou and Crews 2006, 
2011), prevents ethanol-induced neuroimmune-gene induction and neurodegeneration. The neuroimmune system also contributes to alcohol- 
drinking behavior, because activation (Blednov et al. 2001) or blockade of this system (Blednov et al. 2011; Liu et al. 2011) increases and 
decreases self-administration, respectively. 
NOTE: AP-1: activator protein-1; CD14: cluster of differentiation 14; ERK: extracellular signal–regulated kinase; IKK: inhibitor of NF-κB; IRAK 1: interleukin-1 receptor–associated kinase 1; JNK: c-jun 
N-terminal kinases; LPS: lipopolysaccharide; MAPK: mitogen-activated protein kinase; MyD88: myeloid differentiation primary response gene 88; NADPH oxidase: nicotinamide adenine dinucleotide 
phosphate-oxidase; PI3K: phosphatidylinositol-4,5-bisphosphate 3-kinase; RIP: receptor interacting protein; TAK1: transforming growth factor beta–activated kinase 1; TRAF: tumor necrosis factor 
receptor–associated factor; TRAM: TRIF-related adaptor molecule; TRIF: TIR-domain-containing adaptor–inducing interferon-beta. 
SOURCE: Adapted from Crews et al. 2011, 2013.
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1 NADPH oxidase is an enzyme that produces reactive oxygen 
species (ROS)—for example, during ethanol metabolism—thereby 
increasing oxidative stress and contributing to cell damage.
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The NF-κB–mediated transcription 
of proinflammatory genes, in turn, is 
amplified within and across cells by 
induction of TLRs and cytokine 
receptors (e.g., those that belong to 
the IL-1β receptor family), which 
induce innate immune gene expres-
sion. Amplification of innate immune 
gene induction across cells and tissues 
can cause pathology, such as sepsis. 
Sepsis and systemic inflammatory- 
response syndrome involve a “cyto-
kine storm.” This potentially fatal 
innate immune reaction consists of 
positive feedback loops between cyto-
kines and immune and tissue cells, 
resulting in highly elevated levels of 
cytokines in the blood, multiorgan 
failure, and death (Osterholm 2005). 
Models of sepsis that involve activa-
tion of an acute phase-like response 
lead to increases in the levels of multi-
ple cytokines in the blood that occur 
in two distinct phases. First, both 
TNF-α and IL-1β levels increase 
during the first several hours after 
infection but then subside. Subsequently, 
levels of HMGB1, a ubiquitously 
expressed, cytokine-like protein that 
can activate TLR4 and potentiate 
cytokine responses, increase about  
16 hours after infection and remain 
elevated for several days (Wang et  
al. 2001). In mouse models, sepsis- 
induced death that occurs several  
days after infection is associated with 
HMGB1 and is prevented by treat-
ment with antibodies blocking 
HMGB1. Survivors of sepsis show 
prolonged increases in serum HMGB1 
and cognitive deficits that can be 
prevented with HMGB1-antibody 
treatment (Chavan et al. 2012). About 
half of the patients released from the 
hospital after surviving a cytokine 
storm–sepsis insult die within 5 years 
(Quartin et al. 1997). Thus, innate 
immune responses can be long lasting 
and can induce pathology long after 
they initially have been activated. 
However, although most studies support 
a central role for NF-κB–mediated 
transcription of proinflammatory 
cytokines, proteases, and oxidases in 
the innate immune response, both the 
precise mechanisms that regulate indi-
vidual cell or cytokine activation and 
the contributions of tissues and cells 
in vivo to amplification of specific 
innate immune genes are poorly 
understood. 
Monocytes are the primary cells 
mediating the innate immune response. 
They are found in all tissues, including 
the brain. Monocytes in the brain, 
which also are referred to as microglia, 
fall into two main categories: proin-
flammatory M1 monocytes/microglia 
and trophic M2 monocytes/microglia. 
M1 monocytes/microglia participate 
in the acute proinflammatory responses 
of the innate immune system; in addi-
tion, they also convey signals to the 
adaptive immune cells (i.e., T and B 
cells) through the MHC molecules 
they carry on their cell surface. These 
signals help create a persistent sensiti-
zation to pathogens (e.g., in the form 
of antibodies that mediate immuniza-
tion). These proinflammatory effects 
occur in response to pathogens as  
well as tissue damage, cell death, and 
degeneration. Thus, M1 microglia and 
other monocyte-like cells consistently 
express multiple cytokine receptors 
and TLRs that, when activated, induce 
innate immune genes, such as proin-
flammatory cytokines, proteases, and 
oxidases, which help to break down, 
process, and remove damaged cells 
and tissue. In contrast, the M2 mono-
cytes/microglia mediate a delayed 
response that initiates wound-healing 
trophic signaling and seem to be criti-
cal for healing. Both monocytes in 
general and brain microglia in particu-
lar can have both proinflammatory 
M1 and trophic M2 phenotypes 
(Colton 2009; Michelucci et al. 2009). 
Although the M1 and M2 pheno-
types are poorly understood, mono-
cyte proinflammatory activation 
clearly is linked to NF-κB–mediated 
transcription of multiple innate 
immune genes. Activation of mono-
cyte NF-κB by both pathogens and 
tissue damage involves TLR4 (see 
figure 1). This receptor responds to 
endotoxin released by certain bacteria 
(e.g., lipopolysaccharide [LPS]) as well 
as to HMGB1. Proinflammatory gene 
induction also is amplified by cytokine– 
receptor-activated release of HMGB1 
that further contributes to innate 
immune gene induction. 
The role of these innate immune- 
signaling molecules is well character-
ized within the immune system, but 
only recently these molecules have 
been discovered to also contribute  
to brain signaling. Thus, studies  
have indicated that MHC molecules 
contribute to brain development 
(Huh et al. 2000), to most neuro- 
degenerative diseases (Gage 2002; Glass 
et al. 2010), and to alcohol and other 
drug dependence (Crews 2012). 
Neuroimmune signaling in the brain 
has not been extensively studied, and 
most knowledge on this subject is 
based on the assumption that mono-
cyte responses elsewhere in the body 
reflect microglial and brain innate 
immune responses. 
The Immune Response in the Brain
The immune system is not normally 
active in the healthy brain. Thus, the 
healthy normal brain does not contain 
antibodies and has only one type of 
immune cell, the microglia. During 
fetal development, neurons, astrocytes, 
and all other brain cells are formed 
from one embryonic structure (i.e., 
the ectoderm), whereas microglia 
migrate from another embryonic 
structure (i.e., the mesoderm) to the 
brain at a specific time (Ginhoux et al. 
2010). In the healthy brain, the number 
of ramified or “resting” microglia 
equals that of neurons, and these  
cells contribute to the integration of 
sensory systems and overall survey  
of the brain milieu (Raivich 2005). 
Along with astrocytes, they modulate 
important metabolic, trophic, and 
synaptic functions in addition to 
responding to brain–damage-induced 
neuroimmune responses (Farina et al. 
2007; Streit et al. 2004). Microglia 
respond to endogenous or exogenous 
insults with distinct morphological 
changes in shape (i.e., they develop 
“bushy” or “amoeboid-like” pheno-
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types) as well as with marked alterations 
in gene expression, including proin-
flammatory innate immune-response 
genes (Graeber 2010). However, it 
sometimes is unclear whether micro-
glia are responding to a brain insult  
or causing it through the release of 
proinflammatory cytokines. Microglia 
respond to and signal through both 
neuroimmune and neurotransmitter 
signals. For example, acetylcholine—
an important neurotransmitter 
involved in multiple brain functions, 
including cognition—inhibits proin-
flammatory activation in both periph-
eral monocytes and brain microglia 
and has anti-inflammatory effects.
Some studies found an increase in 
the expression of the microglial marker 
Iba-1 in the brains of alcoholic indi-
viduals (see figure 2) (He and Crews 
2008), suggesting that microglia 
contribute to the neurobiology of 
alcoholism. Microglia in postmortem 
human alcoholic brain and chronic 
alcohol-treated mouse and rat brain 
show increased MHC gene expression, 
but not the bushy or phagocytic acti-
vation profiles associated with marked 
brain damage. Chronic ethanol treat-
ment also increases microglial TLR4 
expression (Vetreno et al. 2013). 
Thus, microglia are the only immune 
cells in healthy brain and are integrated 
into the brain’s responses to both 
neurotransmitters and neuroimmune 
signals. They also seem to contribute to 




Chronic binge-drinking models 
repeatedly found that ethanol expo-
sure increases the expression of a vari-
ety of neuroimmune genes in the 
brain and that these alterations may 
persist over long periods (see figure 1). 
For example, one study found that 
chronic ethanol exposure induced the 
neuroimmune gene cyclooxygenase 2 
(COX2) in multiple cortical and 
limbic brain regions long after physi-
cal signs of withdrawal had subsided 
(Knapp and Crews 1999). However, 
ethanol did not induce COX2 in 
transgenic mice lacking TLR4, 
suggesting that this process involves 
TLR4 (Alfonso-Loeches et al. 2010). 
Chronic alcohol exposure also altered 
the activity of NF-κB and another 
regulatory protein, cyclic AMP- 
responsive element binding protein 
(CREB). Specifically, ethanol treat-
ment of HEC brain slice cultures 
increased NF-κB binding to DNA 
probes modeling gene promoter 
regions and decreased CREB binding 
to DNA probes modeling CREB-
responsive gene promoter DNA (Zou 
and Crews 2006). 
The CREB family of transcription 
factors is activated by phosphoryla-
tion; they promote neuronal survival, 
protecting neurons from excitotoxicity 
and apoptosis by regulating the tran-
scription of pro-survival factors (Lonze 
and Ginty 2002; Mantamadiotis et al. 
2002). Conversely, NF-κB is known 
widely for its ubiquitous roles in 
inflammatory and immune responses 
(O’Neill and Kaltschmidt 1997). 
Accordingly, NF-κB and CREB have 
different target genes. For example, 
CREB targets the neuropeptide Y  
and brain-derived neurotrophic factor 
(BDNF) genes, both of which are 
involved in promoting neuronal 
growth and resilience to insults, 
including protection against excitotox-
icity and neuronal death (Lonze and 
Ginty 2002). Regular excitation of 
neurons increases synaptic plasticity 
related to CREB and induces synaptic 
proteins and BDNF. In contrast, 
excessive excitation triggers activation 
of certain extrasynaptic receptors for 
the neurotransmitter glutamate (i.e., 
N-methyl-d-aspartate [NMDA] recep-
tors) and excitotoxicity, resulting in 
either rapid or delayed neuronal  
death, which is associated with reduced 
CREB (Hardingham and Bading 
2010). Chronic ethanol exposure 
interferes with the normal functions  
of CREB. Thus, the levels of CREB 
phosphorylation and CREB–DNA 
binding as well as of the target gene 
BDNF all were decreased in the rat 
Figure 2    Microglial activation, as indicated by expression of the microglial marker Iba-1, is 
increased in postmortem alcoholic brain. The photomicrographs depict microglia 
from postmortem brain samples of alcoholics and control subjects. The number of 
Iba-1–positive microglia (dark stains) is higher in the alcoholic than in the control samples. 
SOURCE: He and Crews 2008.
Iba-1–Positive Microglia 
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frontal cortex following a 24-hour 
withdrawal from chronic ethanol 
exposure (Pandey et al. 1999, 2001). 
In addition, neuropeptide Y levels 
were reduced in the cortex following 
ethanol treatment, an effect that was 
accompanied by reduced levels of 
phosphorylated CREB (Bison and 
Crews 2003). 
The reciprocal relationship between 
NF-κB and CREB transcription sensi-
tizes neurons to excitotoxicity (Zou 
and Crews 2006). This reciprocal rela-
tionship appears to result from the 
actions of kinases, such as protein 
kinase A, which activate CREB tran-
scription but inhibit NF-κB activation. 
However, the reciprocal relationship 
also may represent differences between 
neuronal and glial signaling pathways, 
because regulation of CREB transcrip-
tion principally occurs in neurons 
whereas NF-κB activation of pro- 
inflammatory genes primarily occurs 
in microglia. 
In summary, ethanol can directly 
increase NF-κB–mediated transcription 
of proinflammatory genes in the brain 
as well as decrease trophic protective- 
factor transcription by reducing CREB 
transcription. Together, these effects 
decrease the brain’s resilience to insults. 
Roles of HMGB1 and TLR4
Ethanol induces neuroimmune genes 
through multiple mechanisms. One 
mechanism involves alcohol-induced 
release of HMGB1,2 which increases 
NF-κB–mediated transcription of 
proinflammatory cytokines (Crews  
et al. 2013; Zou and Crews 2014). 
Several transmitters and neuro- 
immune-signaling receptors as well as 
neuronal excitability increase the release 
of HMGB1 (Maroso et al. 2010). This 
protein is a TLR4 agonist that acts 
through multiple signaling mechanisms 
in the brain, thereby influencing astro-
cytes and microglia, as well as neuro-
genesis, neurite growth, and excitability 
in adjacent neurons. HMGB1 released 
by neuronal activity stimulates TLR4 
2 HMGB1 also is known as amphoterin (Huttunen and Rauvala 
2004). 
receptors, resulting in IL-1β release 
and increased phosphorylation of a 
subunit of the NMDA receptor (i.e., 
the NR2B subunit), which in turn 
increases susceptibility to seizures 
(Maroso et al. 2010; Vezzani et al. 
2011). Actively released HMGB1  
is acetylated, and ethanol increases 
HMGB1 acetylation in brain slice 
cultures. The acetyl-HMGB1 initially 
is found primarily in the cell’s cytosol, 
likely in vesicles, before its concentra-
tion in the surrounding fluid increases 
progressively, consistent with neuronal 
release (Zou and Crews 2014). The 
importance of ethanol-induced release 
of HMGB1 and resulting TLR4 acti-
vation to ethanol-induced neurode-
generation and behavioral pathology 
was demonstrated in studies using 
cells and animals that no longer 
produced TLR4 (i.e., TLR4 knockout 
cells and mice). The experiments 
showed that knockout of TLR4 mark-
edly blunted chronic–ethanol-induced 
neurodegeneration and induction of 
proinflammatory gene expression 
(Alfonso-Loeches et al. 2010; Blanco 
et al. 2005; Fernandez-Lizarbe et al. 
2009; Pascual et al. 2011; Valles et  
al. 2004). 
Additional studies found that etha-
nol treatment induced neuroimmune 
genes in microglia and astrocyte 
primary cultures as well as in mice and 
that this induction was dependent on 
the expression of TLR4. These recep-
tors are always present on microglia, 
making microglia a key component  
of drug-induced neuroimmune activa-
tion (Alfonso-Loeches and Guerri 
2011; Schwarz and Bilbo 2013). In 
addition, TLR4 is integral to ethanol- 
induced dopamine release (Alfonso-
Loeches and Guerri 2011), damage to 
white matter (Alfonso-Loeches et al. 
2012), and other pathologies associ-
ated with chronic–ethanol-induced 
changes in the brain (Pascual et al. 
2011). In cultured cells, ethanol treat-
ment increases innate immune gene 
expression in a time-dependent fash-
ion, mimicking responses to LPS or 
IL-1β administration, although etha-
nol induces a much smaller response 
(Crews et al. 2013). In vivo, ethanol 
induces neuroimmune genes in the 
brains of wild-type mice, but not 
TLR4 knockout mice (Alfonso-
Loeches et al. 2010). These studies 
support the hypothesis that TLR4 
signaling is critical to many of the 
effects of alcohol on the brain. 
It is not clear why signaling through 
TLR4 but not via other cytokine 
receptors seems to contribute signifi-
cantly to ethanol responses, because all 
of these receptors generally belong to 
the same receptor superfamily (i.e.,  
the TLR–IL1-R superfamily) (Wald  
et al. 2003) and share kinase cascades 
in monocytes and microglia that all 
converge upon NF-κB. The findings 
suggest that the TLR4s on neurons or 
other brain cells may have some unique 
properties that differ from NF-κB 
activation by receptors for TNF-α, 
IL-1β, and other cytokines (e.g., TNF 
receptor) which induce NF-κB tran-
scription of proinflammatory cyto-
kines. Further complicating the 
picture, the TLR4 signaling pathway 
is not the only one affected by ethanol 
exposure. Vetreno and colleagues 
(2013) found that chronic intermit-
tent treatment of adolescent rats also 
led to persistent increases in the 
expression of another receptor stimu-
lated by HMGB1, called receptor  
for advanced glycation end products 
(RAGE) (see figure 1). Although the 
mechanisms remain complicated, 
together these studies suggest that 
HMGB1–TLR4 and perhaps RAGE 
signaling (which are found on multiple 
brain cells types) as well as neuronal–
glial neuroimmune signaling and 
microglial–astrocyte activation all 
contribute to alcohol-induced brain 
damage. 
Effects of Acute vs.  
Chronic Ethanol Exposure
Although chronic alcohol treatment 
increases proinflammatory gene 
expression in the brain through activa-
tion of TLR4, this is confounded by 
acute alcohol inhibition of TLR4 
signaling in monocytes and possibly 
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other cells. Time-dependent acute and 
chronic opposing effects of ethanol 
confound many studies (Crews et al. 
2006a, 2011; Szabo and Mandrekar 
2009). Acute ethanol suppresses the 
innate immune response to LPS, a 
TLR4 agonist, in both in vivo and in 
vitro models. For example, LPS-induced 
TNF-α and IL-1β production is 
blunted in blood monocytes obtained 
from healthy human volunteers after 
acute alcohol exposure (Crews et al. 
2006a; Szabo et al. 1993, 1995, 
2001). In animal models, acute etha-
nol exposure attenuates the TNF-α, 
IL-1β, and IL-6 immune responses to 
LPS (Pruett et al. 2004). Similarly, in 
in vitro models, addition of ethanol 
(25 mM) just before LPS blunts 
induction of TNF-α (Szabo et al. 
1993, 1995, 2001). In contrast, chronic 
in vitro ethanol exposure of astrocytes, 
microglia, and brain slices induces 
NF-κB transduction of proinflamma-
tory genes through activation of TLR4 
signaling (Crews et al. 2013; Fernandez- 
Lizarbe et al. 2009; Zou and Crews 
2014). 
While it is unclear if the presence  
of acute ethanol exposure antagonizes 
TLR4 on all cell types, other TLRs are 
not acutely blocked by ethanol (Crews 
et al. 2006a). Upregulation of TLRs by 
chronic alcohol treatment can lead to 
sensitization. In mice, binge treatment 
with ethanol for 10 days (5 g/kg/day), 
followed by LPS 24 hours later when 
alcohol had cleared, resulted in a 
marked increase in proinflammatory 
gene induction (Qin and Crews 
2012b). Ethanol treatment increased 
the responses to LPS-induced proin-
flammatory cytokines in liver, blood, 
and brain. The responses were tran-
sient in blood and liver but were long 
lasting in brain. Similarly, chronic 
10-day alcohol treatment sensitized 
mice to the proinflammatory response 
to Poly:IC, a compound that activates 
TLR3 (Qin and Crews 2012a). Thus, 
the effects of ethanol on brain neuro-
immune signaling are in part related 
to increases in TLRs (see figure 1)  
that increase neuroimmune signaling 
and cytokines, such as IL-1β, during 
chronic ethanol treatment, although 
the presence of alcohol can blunt 
TLR4 responses during intoxication. 
Ethanol Induction of HMGB1–TLR 
Signaling in the Brain
As mentioned previously, studies 
investigating the mechanisms of etha-
nol induction of proinflammatory 
genes in the brain have shown that 
chronic ethanol increases expression  
of TLRs as well as the TLR4 receptor 
agonist HMGB1. Studies of chronic 
10-day ethanol treatment of mice 
(Crews et al. 2013), chronic in vitro 
treatment of rat brain-slice cultures 
(Zou and Crews 2014), and analyses 
of postmortem human alcoholic brain 
(Crews et al. 2013) all found increased 
expression of HMGB1, TLR4, TLR3, 
and TLR2 (see figure 3).3 Increases in 
receptors and agonists are common in 
innate immune signaling, and these 
findings suggest that chronic alcohol, 
through induction of HMGB1 and 
TLR4 as well as the less well character-
ized RAGE receptor, may contribute 
to increases in neuroimmune-gene 
expression. Brain-slice culture experi-
ments found that ethanol could 
induce HMGB1 release, which then 
increased proinflammatory gene 
expression. This process could be 
blocked by pharmacological antago-
nists or knockdown of TLR4 (Crews 
et al. 2013; Zou and Crews 2014). 
Studies in adolescent rats (Vetreno 
and Crews 2012), adolescent mice 
(Coleman et al. 2014), and adult  
mice (Qin et al. 2007, 2008, 2013) 
found long-lasting increases in neuro- 
immune-gene induction following  
alcohol treatment. 
In humans, levels of HMGB1  
and TLR expression in specific brain 
regions (e.g., the orbitofrontal cortex) 
have been shown to correlate with life-
time alcohol consumption (Crews et 
al. 2013) (see figure 4). Alcoholic 
subjects who vary greatly in the dura-
tion and amounts of active drinking 
3 Researchers have identified 13 TLRs (i.e., TLR 1-13) in mam-
mals (Medzhitov 2001; Takeda et al. 2003); however, only TLR2, 
TLR3, and TLR4 have been assessed in alcoholic brain. 
bouts exhibited a large variation in 
lifetime alcohol consumption that 
correlated with increased HMGB1–
TLR expression in the frontal cortex. 
In contrast, moderate-drinking 
humans consumed much less alcohol 
than alcoholics and exhibited much 
lower HMGB1–TLR expression. This 
interesting correlation only could 
occur if ethanol induction of HMGB1– 
TLR was persistent and cumulative 
with binge-drinking episodes (see 
figure 4). Together, these studies 
suggest that HMGB1–TLR4 signaling 
is increased by chronic binge drinking, 
contributing to the persistent and 
sustained induction of proinflamma-
tory signaling in brain. 
Mechanisms of 
Neurodegeneration Related  
to Alcohol’s Effects on 
Neuroimmune Signaling  
in the Brain
Role of NADPH Oxidase and 
Oxidative Stress 
One innate immune gene induced by 
ethanol and LPS is NADPH oxidase, 
a multi-subunit enzyme that catalyzes 
the formation of the reactive oxygen 
species (ROS), superoxide, and 
thereby increases oxidative stress. 
NADPH oxidase first was character-
ized as a phagocytic oxidase in mono-
cytes, where it was hypothesized to 
contribute to the oxidation of infec-
tious agents. The superoxide produced 
by NADPH oxidase can increase 
NF-κB transcription, thereby creating 
another amplifying loop of proinflam-
matory signaling (see figure 1). More 
recent studies have found that there 
are multiple genes and forms of 
NADPH oxidase. 
Qin and Crews (2012b) discovered 
that LPS and ethanol can increase 
expression of NADPH oxidase subunits, 
particularly the superoxide-forming 
gp91phox subunit, in the brain and  
that ethanol treatment of mice 
increased superoxide formation in  
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the brain as well as neuronal death. 
Inhibition of oxidases both reduced 
superoxide formation and protected 
against alcohol-induced neuronal 
death. Other studies in mice demon-
strated that LPS treatment induced 
neuroimmune-gene expression, 
NADPH-oxidase activity, and oxida-
tive stress that persisted for at least 20 
months and led to neurodegeneration 
(Qin et al. 2013). Prolonged induc-
tion of NADPH oxidase and oxidative 
stress in the brain could contribute to 
the persistent increase in NF-κB tran-
scription observed after alcohol expo-
sure, because ROS can activate 
NF-κB. These findings are consistent 
with the hypothesis that oxidative 
stress, by inducing innate immune 
genes, significantly contributes to 
alcoholic brain damage and alcoholic 
neurodegeneration. 
In addition to enhancing ROS 
levels, alcohol exposure decreases 
endogenous antioxidant levels, thereby 
reducing the body’s natural defense 
against ROS and again increasing 
oxidative stress (Henderson et al. 
1995). Specifically, ethanol decreases 
the levels of the antioxidant glutathi-
one and the cellular activity of antioxi-
dative enzymes, such as glutathione 
peroxidase, catalase, and superoxide 
dismutase. Furthermore, a synthetic 
superoxide dismutase/catalase mimetic 
(EUK-134) and a water-soluble analog 
of vitamin E (Trolox), both of which 
are well-known antioxidants, protected 
developing hypothalamic neurons from 
oxidative stress and cellular apoptosis 
caused by ethanol-treated microglia 
medium (Boyadjieva and Sarkar 2013). 
Role of Hyperexcitability  
and Excitotoxicty
Another mechanism contributing to 
alcoholic neurodegeneration and asso-
ciated with HMGB1–TLR4 signaling 
is the excessive stimulation of recep-
tors that results in neuron damage  
and cell death (i.e., excitotoxicity). 
Chronic ethanol treatment of neurons 
leads to increased sensitivity to excito-
toxicity (Chandler et al. 1994). This 
effect primarily involves the neuro- 
transmitter glutamate and its receptors. 
Figure 3   Alcohol increases high-mobility group box 1 (HMGB1) expression in mouse brain, and human brain and induces HMGB1 release  
from rat brain slices. (Left) Chronic ethanol treatment of mice for 10 days increases expression of HMGB1 mRNA and protein.  
(Middle) Postmortem human alcoholic orbitofrontal cortex (OFC) has significantly more HMGB1-immunoreactive cells than seen in  
age-matched moderately drinking control subjects. (Right) Ethanol causes the release of HMGB1 into the media from hippocampal- 
entorhinal cortex (HEC) slice culture.
NOTE: ** P < 0.01, relative to the corresponding control group. 
SOURCE: Adapted from Crews et al. 2013. 
C57BL/6 mice Human Brain Wistar Rat HEC
(EtOH: 5g/kg, i.g. 10 days)
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However, the relationship between 
ethanol and glutamate receptors is 
complex. Thus, although ethanol 
enhances overall glutamate excitotox-
icity, in neuronal primary cultures it 
blocks excitotoxicity associated with  
a specific type of glutamate receptor 
(i.e., the NMDA receptor). This is 
consistent with many studies finding 
that ethanol inhibits NMDA receptors 
(Chandler et al. 1998). Yet at the  
same time, HMGB1–TLR4 signaling 
(Balosso et al. 2014) and IL-1β recep-
tor signaling (Viviani et al. 2003)—
both of which, as described above, are 
induced by chronic ethanol—increase 
NMDA receptor-mediated calcium 
flux, neuronal excitability, and excito-
toxicity through activation of kinase 
signaling cascades, including activa-
tion of Src kinase and tyrosine-kinase 
(see figure 5). Furthermore, Suvarna 
and colleagues (2005) found that 
ethanol increases NMDA excitability 
in the hippocampus through kinase 
activation that alters receptor traffick-
ing, leading to increased numbers  
of NMDA receptors containing the 
NR2B subunit at the synapse.
Another mechanism through which 
chronic ethanol induces hyperexcit-
ability involves neuroimmune inhibi-
tion of glial glutamate transporters 
(Zou and Crews 2005). Thus, in 
brain-slice cultures, ethanol potenti-
ates excitotoxicity by causing blockade 
of the molecules that normally remove 
glutamate from the synapse into glial 
cells and may perhaps even induce 
glutamate release from those cells 
(Zou and Crews 2006, 2010). 
As indicated above, ethanol causes 
HMGB1 release, creating hyperexcit-
ability that disrupts synaptic plasticity 
and sensitizes to excitotoxicity. 
HMGB1 is massively released during 
brain damage, resulting in persistent 
neuroimmune-gene induction (Kim  
et al. 2006). Maroso and colleagues 
(2010) found that increased HMGB1 
release was associated with hippocam-
pal excitability that caused seizures, 
leading to persistent increases in 
HMGB1 and excitability. Ethanol  
has modest cumulative effects with 
repeated chronic exposure, further 
exacerbating excitability and excito-
toxicity resulting from increased 
neuroimmune signaling. Thus, the 
global neurodegeneration associated 
with alcoholism, with the most severe 
losses observed in the frontal cortex,  
is secondary to the persistent and 
progressive neuroimmune activation. 
Neuroimmune-Gene Expression 
in Postmortem Human 
Alcoholic Brain 
In addition to the HMGB1–TLR4 
signaling cascade, multiple other 
proinflammatory genes are increased 
and have been detected postmortem 
in the brains of alcoholics. Initial 
 
Figure 4  Cycles of chronic alcohol consumption lead to persistently increased neuroimmune- 
gene expression. (Top) Repeated ethanol (EtOH) binges result in increased brain  
neuroimmune activation (i.e., microglial and astrocytic activation as well as upregulated 
neuroimmune-gene expression). (Bottom) In humans, lifetime alcohol consump-
tion is positively correlated with neuroimmune signal immunoreactivity. Symbols  
indicate levels of Toll-like receptor (TLR) 2, TLR3, TLR4, and high-mobility group box 1 
(HMGB1) in individual moderate drinkers and alcoholics. Results for moderate 
drinkers are clustered along the Y-axis because of their low lifetime alcohol  
consumption and similar neuroimmune expression. Alcoholic subjects show a  
more than 10-fold variation in lifetime alcohol consumption as well as considerable 
variation in expression of all four neuroimmune genes. 
NOTE: Correlations are as follows: TLR2: r = 0.66 (p < 0.01); TLR3: r = 0.83 (P < 0.001); TLR4: r  = 0.62 (P < 0.01);  
HMGB1: r = 0.83 (P < 0.001). 
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human brain studies focused on 
microglia and the proinflammatory 
cytokine monocyte chemotactic  
protein-1 (MCP-1, also known as 
CCL2), which among the cytokines 
tested was induced most robustly by 
ethanol in brain-slice cultures (Zou 
and Crews 2012). Additional studies 
also showed increased levels of MCP-1 
protein in the ventral-tegmental area, 
amygdala, nucleus accumbens, and 
hippocampus (He and Crews 2008). 
In addition to MCP-1, expression of 
the microglial marker Iba-1 also was 
increased. These studies indicate that 
neuroimmune-gene expression is 
increased in the human alcoholic brain. 
Subsequent studies focusing on  
the prefrontal cortex, specifically the 
orbital frontal cortex (OFC), found 
increased levels of HMGB1 as well as 
TLRs (specifically TLR2, TLR3, and 
TLR4) in postmortem alcoholic brain 
(Crews et al. 2013). Furthermore, 
NADPH oxidase was increased in 
alcoholic OFC, consistent with 
increased oxidative stress as found in 
mice. The HMGB1 receptor RAGE 
also was increased in postmortem 
human alcoholic brain (Vetreno et  
al. 2013). Finally, studies detected 
increased IL-1β inflammasome mark-
ers in the hippocampus of postmortem 
alcoholic brains that could contribute 
to loss of neurogenesis. These observa-
tions indicate that multiple neuro- 
immune genes are increased in alcoholic 
brain and likely contribute to neuro-
degeneration and the neurobiology  
of alcoholism in humans. 
Researchers also investigated the 
relationship between alcohol drinking 
and neuroimmune-gene expression  
in alcoholics and control subjects. 
Interestingly, two forms of correla-
tions were found linking neuro- 
immune-gene expression to alcohol 
consumption and alcoholism. The  
first correlation involved the age at 
drinking onset (Vetreno et al. 2013). 
Adolescent drinking is known to 
increase risk of developing alcohol 
dependence, with the risk decreasing 
with every year of delaying alcohol-use 
initiation across adolescence (for more 
information, see the sidebar). Studies 
found that in the OFC, a negative 
Figure 5  Simplified schematic depicting how neuroimmune signaling leads to neuronal hyperexcitability and the neurobiology of addiction. 
Alcohol and stress activate neurons and glia in the central nervous system, resulting in the release of various neuroimmune signals (e.g., 
high-mobility group box 1 [HMGB1] and interleukin-1beta [IL-1β]) that activate neuroimmune receptors (e.g., Toll-like receptors [TLRs]). 
Neuroimmune receptor stimulation leads to phosphorylation, and thus activation, of glutamatergic N-methyl-d-aspartate (NMDA) receptors 
that are transported to the cell surface (Iori et al. 2013; Maroso et al. 2010). The increased number of NMDA receptors increases Ca2+ 
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correlation existed between HMGB1–
TLR4 expression and age at drinking 
onset, with lower HMGB1–TLR4 
expression in individuals who initiated 
alcohol use later. The second correla-
tion involved the amount of alcohol 
consumed, with total lifetime alcohol 
consumption positively correlated 
with OFC expression of HMGB1, 
TLR4, TLR3, TLR2, and RAGE 
(Crews et al. 2013). These findings 
further support the role of neuro- 
immune signaling in alcoholic brain 
and alcoholic neurodegeneration.
Role of Microglia in Mediating 
Alcohol Actions in the Brain
Given their role in facilitating inflam-
mation, it is not surprising that  
alcohol-activated microglia have been 
implicated in alcohol-induced inflam-
matory pathways. In rats, intermittent 
and chronic alcohol exposure can acti-
vate microglia while concomitantly 
increasing expression of proinflamma-
tory cytokines and neuronal cell death, 
providing indirect evidence for the 
role of microglia in alcohol-induced 
neuroinflammation and neurotoxicity 
(Alfonso-Loeches and Guerri 2011; 
Chastain and Sarkar 2014; Zhao et al. 
2013). Alcohol can activate microglia 
directly, via stimulation of TLRs, or 
indirectly, via neuronal damage and 
subsequent release of damage-associated 
molecular patterns that include 
HMGB1, resulting in the accumulation 
of microglia in the brain (i.e., reactive 
microgliosis) (Alfonso-Loeches and 
Guerri 2011). Microglial TLR4 seems 
to be necessary in alcohol- induced 
activation of microglia and subsequent 
microglial production of inflammatory 
mediators and apoptosis of neighboring 
neurons (Fernandez-Lizarbe et al. 2009, 
2013). In an in vitro study (Boyadjieva 
and Sarkar 2010), microglia-conditioned 
media enhanced ethanol-induced 
apoptosis of cultured hypothalamic 
neurons. Interestingly, the neuronal cell 
death induced by microglia-conditioned 
media could be abolished if TNF-α 
was inactivated in the cultured cells, 
suggesting that microglial TNF-α 
production plays a key role in ethanol- 
induced neurotoxicity in developing 
neurons. The mechanism by which 
alcohol induces neuronal cell death 
may involve upregulation of NF-κB 
expression, which then stimulates 
release of TNF-α, resulting in neuronal 
apoptosis (Crews and Nixon 2009; 
Guadagno et al. 2013). Stimulation  
of the transcription factor AP-1 and 
release of IL-1β, IL-6, and transform-
ing growth factor β (TGF-β1) also 
may contribute to alcohol-induced 
neuronal apoptosis (Alfonso-Loeches 
and Guerri 2011; Chen et al. 2006).
In addition to releasing cytokines, 
stimulated microglia contribute to 
neurotoxicity by secreting ROS 
(Takeuchi 2010). ROS, such as super-
oxide, hydrogen peroxide, and nitric 
oxide, can break down cell membranes 
and induce cell death. After alcohol 
exposure, ROS levels increase both  
as a natural byproduct of alcohol 
metabolism and as a result of 
enhanced cellular respiration, thus 
creating oxidative stress and leading  
to neuronal cell death (Guerri et al. 
1994; Montoliu et al. 1995). Several 
studies have implicated microglia in 
the alcohol-induced production of 
ROS and resulting neurotoxicity.  
Qin and Crews (2012a) demonstrated 
that mice exposed to chronic alcohol 
showed increased levels of NADPH 
oxidase, superoxide, microglial activa-
tion, and cell death in cortical and 
hippocampal brain regions. Inhibition 
of NADPH oxidase during alcohol 
administration decreased superoxide, 
microglial activation, and cell death, 
directly linking ROS production to 
alcohol-induced microglial activation 
and neurotoxicity. In accord with 
these in vivo findings, in vitro studies 
showed that microglia-conditioned 
media enhanced ethanol-induced 
ROS production and oxidative stress 
in cultured hypothalamic neuronal 
cells and increased apoptotic cell  
death (Boyadjieva and Sarkar 2013a). 
Through these mechanisms, as well  
as the ethanol-related decreases in 
antioxidants discussed earlier, ethanol- 
activated microglia can induce apop-
totic cell death and cell death in 
cultured fetal hypothalamic neurons 
from rat, suggesting that microglia 
may help facilitate ethanol-induced 
neurotoxicity by ROS.
Another cellular signaling mecha-
nism by which alcohol induces neur-
onal apoptosis involves increased 
neuronal release of TGF-β1. Alcohol-
induced elevation of TGF-β1 levels  
in neuronal cells is accompanied by  
a host of molecular and chemical 
changes related to cell death, includ-
ing the following (Chen et al. 2006; 
Kuhn and Sarkar 2008):
• Increased expression of a protein 
called E2F1, whose overexpression 
sensitizes cells to apoptosis;
• Reduced expression of two key 
regulators of cell-cycle progression 
(i.e., cyclin D1 and cyclin-dependent 
kinase-4);
• Elevated levels of mitochondrial 
proapoptotic proteins bak, bad, 
and bcl-xs;
• Lowered levels of the antiapoptotic 
protein bcl-2; and
• Increased production of the apop-
totic enzyme caspase 3.
Interestingly, in transformed cells, 
inhibition of NF-κB or ROS abro-
gates TGF-β1 stimulation of cell 
functions (Tobar et al. 2010). Hence, 
the ROS–NF-κB–TGF-β1 signaling 
cascade is a possible mechanism by 
which alcohol induces the apoptotic 
process in neurons—a process that  
is modulated by microglia. Another 
mechanism might relate to the 
microglial ability to reduce production 
of BDNF and cyclic adenosine  
monophosphate (cAMP) in neurons 
following ethanol activation. Thus, 
hypothalamic neuronal cell cultures 
treated with ethanol-activated microglia- 
conditioned medium showed decreased 
levels of both of these compounds. 
Treatment with BDNF or dibutyryl 
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cAMP decreased the changes in the 
levels of intracellular free radicals, 
ROS, nitrite, glutathione, and catalase 
as well as neuronal apoptotic cell 
death that otherwise occurred when 
these cultures were treated with ethanol- 
activated microglia-conditioned 
medium. These findings suggest that 
ethanol increases the production of 
certain microglia-derived factors, 
thereby reducing cellular levels of 
cAMP and BDNF and increasing 
cellular oxidative stress and apoptosis 
in neuronal cells (Boyadjieva and 
Sarkar 2013b). However, further studies 
are needed to fully elucidate the mech-
anism(s) by which ethanol-activated 
signaling induces neuronal death. 
Microglia also may mediate the 
effects of alcohol administration  
on the development of new neurons 
(i.e., neurogenesis). Alcohol exposure 
can result in decreased hippocampal 
neurogenesis, an effect that may 
underlie alcohol-related neurodegen-
eration (Crews et al. 2006; Morris et 
al. 2010). However, alcohol exposure 
followed by a period of abstinence 
results in increased hippocampal 
neurogenesis, which may serve a 
regenerative purpose. Interestingly, 
this process is preceded by microglial 
proliferation, raising the possibility 
that microglia may facilitate some 
regenerative mechanisms in recovery 
from alcohol exposure (McClain et al. 
2011; Nixon et al. 2008).
In addition to being implicated  
in alcohol-induced neurotoxicity, 
microglia also might contribute to the 
processes that lead to the development 
of alcohol use disorder. Recent studies 
in rodents support a role for microglia 
in voluntary alcohol drinking and 
preference. In a quantitative-trait 
locus analysis of six strains of mice 
that differ in voluntary alcohol-  
drinking behavior, alcohol-preferring 
animals exhibited an increase in the 
expression of β-2-microglobulin,  
an NF-κB target gene involved in 
microglial MHC immune signaling 
(Mulligan et al. 2006). In addition, 
knockout of the β-2-microglobulin 
gene in mice decreased voluntary  
alcohol consumption and preference 
(Blednov et al. 2012). Finally, treat-
ment with minocycline, an antibiotic 
and selective inhibitor of microglia, 
reduced voluntary alcohol consump-
tion in adult mice (Agrawal et al. 
2014). These studies suggest microglia 
might mediate alcohol preference and 
might contribute to the development 
of alcohol use disorder.
Neuroimmune Signaling 
Integrates CNS Responses  
to Alcohol and Stress
The Stress Axis and the Peripheral 
Immune System 
Alcohol activation of immune signals 
and cytokine production in the brain 
affects not only cellular functions in 
the brain but also immune-system 
function in the periphery. The body’s 
main stress response systems—the 
hypothalamic–pituitary–adrenal 
(HPA) axis and the sympathetic 
nervous system (SNS)—are major 
pathways by which the brain and the 
immune system communicate. When 
the HPA axis is activated by a stressful 
situation, the hypothalamus releases 
corticotropin-releasing hormone 
(CRH), which acts on the pituitary to 
induce the release of adrenocortico-
tropic hormone. This hormone in 
turn acts on the adrenal glands to 
stimulate the release of stress hormones 
(i.e., glucocorticoids), including corti-
sol in humans and corticosterone in 
rodents. These hormones then help 
coordinate the body’s response to the 
stress. The SNS is part of the auto-
nomic nervous system that regulates 
the body’s unconscious activities to 
maintain its normal functions. One  
of the main processes coordinated by 
the SNS is the fight-or-flight response 
to stress.
Alcohol has a potent activating 
effect on the HPA axis as well as on 
neuroimmune signaling; therefore, 
these effects may integrate the 
responses of the central nervous 
system (CNS) to alcohol and stress 
(figure 6). For example, TNF-α, 
IL-1β, and IL-6 act upon the HPA 
axis and SNS, both directly via local 
effects and indirectly via the CNS 
(Besedovsky and del Rey 1996; 
Pickering et al. 2005; Wilder 1995). 
Furthermore, CRH has a variety of 
complex effects on immune cells 
(Elenkov et al. 1999) and modulates 
immune/inflammatory responses 
through receptor-mediated actions of 
glucocorticoids on anti-inflammatory 
target immune cells (Tsigos and 
Chrousos 2002). In contrast, elevated 
glucocorticoid levels in the prefrontal 
cortex are proinflammatory, potentiat-
ing LPS–TLR4 activation of NF-κB 
and other proinflammatory signals 
(Munhoz et al. 2010). The neuro- 
transmitter norepinephrine that is 
released by SNS activation also 
disturbs inflammatory cytokine 
networks and innate immune-cell 
function. Similarly, the hypothalamic 
peptide β-endorphin (BEP), whose 
release is stimulated by CRH during 
HPA activation, can inhibit stress- 
hormone production and activate 
peripheral immune functions (Sarkar 
and Zhang 2013). All of these findings 
suggest that the stress–HPA axis, 
commonly thought to involve anti- 
inflammatory glucocorticoid actions, 
also contributes to stress–alcohol 
responses in the brain that can increase 
proinflammatory HMGB1–TLR–
cytokine signaling. 
HPA hormones influence the 
immune system in multiple ways 
(figure 6). Glucocorticoids prevent  
the migration of leukocytes from the 
circulation into extravascular regions, 
reduce accumulation of various 
immune cells (i.e., monocytes and 
granulocytes), and suppress the 
production and/or action of many 
cytokines and inflammatory mediators 
(Hermann et al. 1995; Sheridan et al. 
1998; Zhang et al. 1998). They also 
inhibit a number of cytokines, including 
IL-1α, IL-1β, IL-6, IL-12, IFN-γ, 
TNF-α, granulocyte-macrophage 
colony-stimulating factor, and chemo-
kine (C-C motif) ligand 5 (RANTES) 
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Adolescence and Persistent Neuroimmune Expression in the Brain
Adolescence is a developmental stage 
characterized by increased play 
behavior, thrill seeking, risk taking, 
puberty, and transition to indepen-
dence. During this stage, the brain 
continues to develop; in particular, 
the frontal cortex continues to exhibit 
structural changes that coincide with 
maturation of adult behaviors and 
executive functions (Ernst et al. 2009). 
The developing brain is uniquely 
sensitive to alcohol, making adoles-
cence a critical period of risk for 
developing alcohol use disorder (AUD) 
(Crews et al. 2007). Adolescence also 
is a period of experimentation, as 
exemplified by findings that alcohol- 
use initiation use typically begins 
during those years. The age of drink-
ing onset is associated with various 
alcohol-related characteristics, includ-
ing prevalence of lifetime AUD, as 
well as violence, fights, and injuries 
associated with alcohol use (Brown  
et al. 2008; Dawson et al. 2008; Sher 
and Gotham 1999). The younger the 
age of drinking onset, the more likely 
the person will develop AUD. In 
addition, binge drinking peaks 
during late adolescence.
The high prevalence of binge drink-
ing among adolescents increases the 
importance of understanding how 
binge drinking might affect the 
adolescent brain. Studies found that a 
younger age of drinking onset is asso-
ciated not only with an increased risk 
of lifetime AUD but also correlates 
with a smaller brain size and greater 
expression of high-mobility group 
box 1 (HMGB1) and Toll-like recep-
tor 4 (TLR4), as well as other neuro-
immune signaling receptors (Vetreno 
et al. 2013). These associations likely 
result both from pre-existing condi-
tions that mature into dysfunctional 
behavior and from alcohol-induced 
factors than change over the life 
course and increase dysfunctional 
behavior, perhaps by altering brain 
maturation. The contributions of 
these two factors can only be deter-
mined by controlled experiments in 
which adolescent alcohol exposure is 
the only variable and genetic and 
other factors play no role. Such stud-
ies cannot be done in humans but are 
being done in animals (primarily rats) 
whose genetic background and envi-
ronment can be controlled. The 
essential need to understand the 
neurobiology and impact of adoles-
cent drinking on adulthood resulted 
in the formation of a consortium 
called NADIA, funded by the 
National Institute on Alcohol Abuse 
and Alcoholism, which addresses the 
contribution of adolescent alcohol 
abuse to adult psychopathology.
Adolescents have an immature 
response to alcohol, characterized by 
unique factors that differ from the 
adult response to alcohol. For example, 
adolescent rats show greater ethanol- 
induced memory impairment in 
certain tasks (e.g., the Morris water 
maze and discrimination tasks) than 
do adults (Land and Spear 2004; 
Markwiese et al. 1998). Similarly, 
humans who initiate alcohol use in 
their early 20s are more sensitive to 
the effects of alcohol on multiple 
memory tasks compared with those 
who start drinking in their late 20s 
(Acheson et al. 1998). Also, compared 
with adults, adolescents exhibit more 
potent inhibition of NMDA receptor- 
mediated synaptic activity in the 
hippocampus (Swartzwelder et al. 
1995) as well as greater induction of 
long-term potentiation (LTP) (Martin 
et al. 1995). Adolescents, who already 
exhibit social behaviors, also are 
uniquely sensitive to the social facili-
tative effects of ethanol (Varlinskaya 
and Spear 2002). Consistent with 
findings in humans, adolescent rats 
are more sensitive to binge-drinking 
models of brain damage, particularly 
in the frontal cortex (Crews et al. 
2006). Interestingly, adolescent rats 
are less sensitive than adults to certain 
effects of alcohol, such as the sedative 
(Little et al. 1996; Silveri and Spear 
1998), motor impairing (Little et al. 
1996, White et al. 2002a,b), social 
inhibitory (Varlinskaya and Spear 
2002), and aversive (Anderson et al. 
2010) effects. Adolescent rats also 
show electrophysiological differences 
from adults in the hippocampus, 
particularly a reduced sensitivity to 
γ-aminobutyric acid (GABA) type A 
(GABAA) receptor-mediated inhibi-
tion (Carr et al. 2003; Sullivan et al. 
2006; Yan et al. 2009, 2010). The 
reduced sedative sensitivity to alcohol 
and increased alcohol-induced cogni-
tive disruption observed in adolescent 
animals is consistent with findings in 
humans that adolescents have high 
rates of binge drinking and are at 
particularly high risk of alcohol-related 
traffic crashes. The continuous increase 
in high binge-drinking levels in 
human adolescents over the past 
decade justifies the need to study the 
long-term consequences of adolescent 
alcohol abuse in more detail.
Like adult alcohol exposure, 
adolescent exposure induces neuro-
immune genes in the brain; further-
more, in humans, the effect on 
neuroimmune genes correlates  
with age of drinking onset. Indeed, 
Vetreno and Crews (2012) found 
that intermittent binge-ethanol treat-
ment in adolescent rats increased 
expression of multiple innate immune 
genes in the frontal cortex during 
adulthood. Interestingly, whereas 
expression of the critical neuroim-
mune signaling receptor TLR4 
decreased during adolescence in 
controls, expression of this receptor 
increased and remained elevated into 
adulthood in adolescents with binge 
ethanol exposure (Vetreno and Crews 
2012). In contrast, the expression  
of HMGB1 in the frontal cortex 
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Adolescence and Persistent Neuroimmune Expression in the Brain (continued)
increased during adolescence in 
control subjects, and this increase  
was exacerbated by adolescent binge 
ethanol exposure. Moreover, adoles-
cent alcohol exposure resulted in a 
persistent increase in adult HMGB1 
and TLR4 levels that may represent 
adolescent-like HMGB1–TLR4 
signaling in these adults.
As mentioned in the main article, 
HMGB1–TLR4 signaling induced 
by alcohol exposure can enhance 
sensitivity at the NMDA glutamate 
receptor, which can counteract etha-
nol’s direct inhibitory effects on this 
receptor. Accordingly, adults with 
persistent increases in HMGB1–
TLR4 signaling resulting from 
adolescent alcohol exposure might 
experience adolescent-like tolerance 
to alcohol’s sedative effects, and 
perhaps increased adolescent-like 
cognitive disruption as well. Although 
adolescent alcohol exposure does not 
markedly disrupt adult learning tasks, 
adolescent intermittent binge expo-
sure induces deficits in reversal learn-
ing in adult rats (Vetreno and Crews 
2012) and mice (Coleman et al. 
2011). These studies are consistent 
with the hypothesis that the adoles-
cent brain is vulnerable to long-lasting 
changes that persist through matura-
tion into adulthood. Persistent 
neuroimmune-gene induction likely 
contributes to continuous slow 
neurodegeneration as well as to more 
specific insults on key neurotransmit-
ters that mature during adolescence 
(Crews et al. 2007; Vetreno and 
Crews 2012) and may also be related 
to a persistent loss of behavioral flexi-
bility. Together, the persistent loss  
of ability to adapt to changes, low 
sedative response to alcohol, and 
increased sensitivity to cognitive 
disruption associated with adolescent 
alcohol exposure all are likely to 
promote and sustain high alcohol- 
drinking levels. These in turn will 
promote more alcohol consumption 
and the chances that AUD will 
develop in addition to alcoholic 
neurodegeneration.
—Fulton T. Crews, Ph.D.; 
Dipak K. Sarkar, Ph.D., D.Phil.; 
Liya Qin, Ph.D.; Jian Zou, Ph.D.; 
Nadka Boyadjieva, M.D., Ph.D., D.Sci.; 
and Ryan P. Vetreno, Ph.D.
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(Sapolsky et al. 2000; Wiegers et al. 
2005). At the same time, glucocorti-
coids increase the activity of TGF-β 
by activating a latent form of the  
cytokine (Oursler et al. 1993), which 
may indirectly affect the immune 
response, because TGF-β inhibits  
activation of T cells and macrophages. 
Glucocorticoids also increase produc-
tion of IL-10, an anti-inflammatory 
cytokine that blocks NF-κB transcrip-
tion and inhibits antigen presentation 
and T-cell activation (de Waal Malefyt 
et al. 1991). Finally, glucocorticoids 
suppress maturation, differentiation, 
and proliferation of immune cells, 
including innate immune cells,  
T cells, and B cells. 
Norepinephrine released after SNS 
activation also disturbs inflammatory 
cytokine networks by inhibiting 
production of immune-enhancing 
cytokines, such as IL-12 and TNF-α, 
and by upregulating production of 
inhibitory cytokines, such as IL-10 
and TGF-β (Webster et al. 2002). 
Additionally, norepinephrine affects 
peripheral natural killer (NK) cells, a 
subset of lymphocytes that are a first-
line defense against viral infections, 
tumor growth, and metastasis via their 
unique cytolytic action (Herberman 
and Ortaldo 1981). These cells carry 
receptors for norepinephrine (i.e., 
β-adrenergic receptors) on their surfaces 
(Madden et al. 1995). The cytolytic 
activity of NK cells involves the syner-
gistic actions of the pore-forming 
protein perforin and the serine prote-
ase granzyme B to cause apoptosis  
of target cells (Graubert et al. 1996). 
Among the HPA hormones, gluco- 
corticoids and CRH both are potent 
inhibitors of NK-cell activity in vitro 
and in vivo. Hypothalamic CRH 
inhibits NK activity and IFN-γ 
production through actiavation of the 
SNS, which causes release of catechol-
amines (e.g., norepinephrine) from  
the spleen and activation of β-adrenergic 
receptors on NK cells (Irwin et al. 1990). 
Thus, it appears that the hormones 
secreted during stress by the HPA axis 
and SNS have inhibitory effects on 
peripheral immune functions that 
contrast with their actions in the CNS.
During activation of the HPA axis, 
secretion of CRH and catecholamines 
also increases the secretion of BEP in 
the hypothalamus. In a feedback 
mechanism, BEP regulates the secre-
tion of CRH in a hypothalamic region 
called the paraventricular nucleus 
(PVN) (Plotsky 1986). In the PVN, 
the BEP-releasing neurons act on 
CRH-releasing neurons and inhibit 
CRH release, thus regulating the 
activity of the stress system (Plotsky  
et al. 1993). BEP acts by binding to  
δ- and μ-opioid receptors; accord-
ingly, treatment with a μ-opioid 
receptor antagonist results in increased 
CRH release (Boyadjieva et al. 2006). 
BEP affects immune-system function 
through a variety of mechanisms. By 
binding to δ- and μ-opioid receptors 
BEP modulates neurotransmission  
in sympathetic and parasympathetic 
neurons via neuronal circuitry within 
the PVN, ultimately resulting in acti-
vation of NK-cell cytolytic functions 
in the spleen (Boyadjieva et al. 2006, 
2009; Sarkar et al. 2011). If incubated 
with human bone marrow mononu-
clear cells  or NK-enriched cell popu-
lations, BEP enhances NK activity 
(Mathews et al. 1983). In animal 
models, chronic BEP infusion into  
the blood vessels in the brain enhances 
NK-cell activity in vivo, and this effect 
is eliminated by the opioid antagonist 
naloxone (Jonsdottir et al. 1996). BEP 
also can inhibit T-cell proliferation 
(van den Bergh et al. 1993) as well  
as antibody production (Morgan et  
al. 1990). 
Abnormalities in BEP neuronal 
function are correlated with a higher 
incidence of cancers and infections  
in patients with schizophrenia, depres-
sion, and fetal alcohol syndrome  
and in obese patients (Bernstein et  
al. 2002; Lissoni et al. 1987; Polanco  
et al. 2010; Zangen et al. 2002). 
Interestingly, BEP-cell transplantation 
in the hypothalamus suppresses vari-
ous cancers in rat models by activating 
innate immune-cell functions and 
altering inflammatory and anti- 
inflammatory cytokine milieus (Sarkar 
et al. 2008). In this setting, chronic 
alcohol use suppresses BEP neuronal 
activity and is connected with 
increased infection rates and higher 
incidence of cancer. Thus, alcohol  
and stress seem to paralyze adaptive 
innate immune functions by inducing 
complex changes in NK cells and 
other adaptive immune signaling that 
in the brain primarily involves micro-
glial–astrocyte–neuronal HMGB1–
TLR signaling.
Effects of Immune System 
Activation on Brain Function
The interaction between the brain  
and the immune system is not  
unidirectional—that is, immune- 
system responses also may influence 
responses in the brain. Recent studies 
indicate that ethanol causes HMGB1 
release in the gut, which activates 
TLR4. As a result, the gut leaks 
LPS-like bacterial products, thereby 
stimulating proinflammatory cytokine 
induction in the liver, which in turn 
leads to increased levels of TNF-α  
and other cytokines in the blood. Qin 
and Crews (2007, 2012b) discovered 
that LPS-induced increases in serum 
TNF-α as well as proinflammatory 
cytokines led to gene induction in the 
brain. The proinflammatory cytokines 
in the blood can be transported across 
the blood–brain barrier (BBB) by 
their receptors (e.g., TNFR) (Banks 
and Erickson 2010; Qin et al. 2007). 
Using intraperitoneal injections of 
LPS to stimulate proinflammatory 
responses in the liver and other tissues 
and induce proinflammatory cyto-
kines, researchers discovered parallel 
increases in TNF-α in the blood and 
brain (Qin et al. 2007). In transgenic 
mice lacking TNF receptors, however, 
LPS increased TNF-α only in the 
blood but not in the brain, suggesting 
that LPS–TLR4 induction of TNF-α 
in the blood leads to TNF transport 
by its receptors across the BBB and 
activation of proinflammatory 
responses in the brain. Transgenic 
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mice without the TNF-α receptor 
cannot transport the cytokine to the 
brain; consequently, the LPS–TLR4 
proinflammatory response is amplified 
across peripheral tissues but does not 
spread to the brain.
Ethanol can increase proinflamma-
tory cytokine levels in the blood by 
activating proinflammatory responses 
in the liver and other tissues. One 
mechanism seems to involve the ethanol- 
induced increase in gut permeability 
(or “leakiness”) mentioned above 
(Ferrier et al. 2006). At high doses (at 
least 2 to 3 g/kg ethanol administered 
into the stomach), ethanol potentiates 
innate immune signaling in the gut 
(Ferrier et al. 2006). This disrupts the 
Figure 6   Neuroimmune signaling integrates central nervous system (CNS) responses to alcohol and stress. (Left) Stressors activate the body’s 
stress response system, which is comprised of the hypothalamus, pituitary gland, and adrenal glands (i.e., HPA axis) as well as the stress  
hormones they produce (e.g., adrenocorticotropic hormone and glucocorticoids). Stress also activates the sympathetic nervous system, 
which secretes catecholamines. These hormones act on various organs and tissues that are part of the immune system. In response, 
immune cells secrete cytokines that via the blood are transported to the brain. There, these cytokines lead to brain neuroimmune-gene 
induction that sensitizes stress-response pathways. At the same time, the immune system communicates with the CNS through sensory 
(afferent) nerves that activate the brain in response to stressful stimuli. This communication pathway involves particularly the vagus nerve 
and the nucleus tractus solitarius in the brain stem. (Right) Alcohol influences neuroimmune signaling via its effects on the gastrointes-
tinal tract. Consumed ethanol enters the stomach and gut and makes them “leaky” by inducing the release of high-mobility group box 
1 (HMGB1), which in turn activates Toll-like receptor 4 (TLR4) in the gut. As a result, bacterial products such as lipopolysaccharide (LPS) 
can enter the blood and reach the liver. Both LPS and ethanol (which also reaches the liver via the circulation) contribute to inflammatory 
reactions in the liver, which lead to release of tumor necrosis factor-alpha (TNF-α) and other proinflammatory cytokines from the liver. 
These proinflammatory cytokines in the blood enter the brain and increase neuroimmune-gene expression. Chronic ethanol also increases 
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connections between the cells lining 
the gut (i.e., gut tight junctions) and 
opens sites that allow gut bacteria and 
their endotoxins to enter the blood 
vessels leading to the liver, where  
they can initiate a proinflammatory 
response (Sims et al. 2010). Thus, 
high doses of ethanol increase systemic 
proinflammatory responses, which  
can then spread to the brain through 
TNF-α and likely other cytokines (see 
figure 6). 
Although some in vitro studies have 
suggested that ethanol can interfere 
with the BBB, most in vivo studies  
do not show BBB damage following 
chronic ethanol treatment. Marshall 
and colleagues (2013) assessed BBB 
integrity by tracking a protein (i.e., 
albumin) that cannot cross an intact 
BBB in rats that were administered 
large amounts of alcohol for 4 days  
(a regimen that can induce alcoholic 
brain damage). The analyses found no 
evidence of albumin in the brain, indi-
cating that the BBB had remained 
intact following the ethanol treatment. 
Using the same model, Crews and 
colleagues (2006) found that inhibi-
tion of NF-κB protected against the 
brain damage and inhibition of neuro-
genesis normally induced by this regi-
men. These findings are consistent 
with the assumption that proinflam-
matory responses in the brain mediate 
brain damage without causing BBB 
damage. Instead, the brain damage 
may be induced through direct activa-
tion of proinflammatory responses in 
the brain and/or systemic proinflam-
matory signals that are transported 
across the BBB and contribute to 
brain proinflammatory responses. 
Although the levels of proinflamma-
tory gene expression in the blood and 
brain parallel each other at early time 
points after initiation of an immune 
response, the brain’s response to LPS 
is much smaller than that found in the 
liver and blood during the first few 
hours. Surprisingly, the blood and 
liver responses to LPS return to base-
line over about 8 to 12 hours, whereas 
the increase in proinflammatory gene 
Glossary 
Antibody: Immune molecule (protein) produced by B 
cells that recognizes foreign molecules that have entered 
the body (i.e., antigens), binds to these molecules, and 
marks them for destruction by the body’s immune system.
Astrocytes: Characteristic star-shaped non-neuronal cells 
in the brain and spinal cord that support the endothelial 
cells that form the blood–brain barrier and provide 
nutrients to the nervous tissue.
Cytokine: Any of a group of molecules, produced primarily 
by immune cells, that regulate cellular interactions and 
other functions; many cytokines play important roles in 
initiating and regulating inflammatory reactions.
Endotoxin: A highly toxic chemical component of 
the cell walls of certain bacteria that occur normally 
in the intestine. Endotoxin can be released into the 
bloodstream when bacteria die or there is an increase in 
gut permeability.
Excitotoxicity: Pathological process by which nerve cells 
are damaged or killed after being excessively stimulated 
by excitatory neurotransmitters (e.g., glutamate).
Kinase: An enzyme that transfers phosphate groups from 
one molecule (the donor) to a specific target molecule 
(the substrate).
Long-term potentiation (LTP): Process by which an 
episode of strong receptor activation at a synapse leads 
to a subsequent long-lasting strengthening of the signal 
transmission across that synapse (e.g., by inducing the 
accumulation of more receptor molecules at that synapse).
Macrophages: A type of immune cell that ingests 
foreign particles and microorganisms in a process called 
phagocytosis and which synthesizes cytokines and other 
molecules involved in inflammatory reactions.
Major histocompatibility complex (MHC): A highly diverse 
set of glycoproteins in the cell membranes of almost 
all cells that help to present foreign molecules (i.e., 
antigens) to other immune cells (i.e., T cells) to activate 
these cells and induce an immune response.
Microglia: Type of non-neuronal cell in the central 
nervous system (CNS) that acts as the first and main 
form of active immune defense in the CNS.
Monocytes: A type of white blood cell involved in the 
innate immune response; upon activation (e.g., in response 
to an infection) they move to the site of the infection, enter 
the tissues, and differentiate into macrophages, which then 
can engulf and destroy the pathogen.
Sepsis: The presence of pathogenic organisms or their 
toxic products in the blood or tissues.
Toll-like receptors (TLRs): A class of proteins that play 
a key role in innate immunity. They are located on 
macrophages as well as other brain cells (i.e., astrocytes 
and neurons) and are activated in response to various 
pathogens; this activation triggers additional innate 
immune responses and, eventually, adaptive immune 
responses.
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expression in the brain persists for 
months. This leads to degeneration of 
dopamine neurons in the substantia 
nigra, a region in the midbrain involved 
in reward and addiction (Qin et al. 
2007). Similarly, liver and blood 
responses to binge alcohol exposure 
appear to be small and transient, 
although they have not been exten-
sively investigated. In contrast, brain 
expression of the proinflammatory 
cytokine MCP-1 persists for at least 1 
week (Qin et al. 2008).
Exposure of C57BL/6 mice to 10 
daily doses of ethanol followed by LPS 
results in increased LPS induction of 
proinflammatory cytokines in the 
liver, blood, and brain compared  
with control animals treated only with 
LPS (Qin et al. 2008). However, this  
ethanol-induced sensitization to the 
LPS response resulted in sustained 
increases in multiple proinflammatory 
cytokines, including TNF-α, IL-1β, 
and MCP-1 only in the brain, but not 
in the liver. The mechanism underly-
ing the sustained brain response and 
transient liver response is not clear. 
The investigators noted that the anti- 
inflammatory cytokine IL-10, which 
inhibits NF-κB, was increased in the 
liver 1 week after alcohol treatment, 
but decreased in the brain (Qin et  
al. 2008). This suggests that anti- 
inflammatory mechanisms may 
contribute to the loss of the liver 
response. Further analyses found that 
mice pretreated with ethanol are sensi-
tized not only to the TLR4 receptor 
agonist LPS but also to the TLR3 
agonist Poly:IC (Qin and Crews 
2012a). Similar to LPS, Poly:IC 
induces proinflammatory genes in the 
brain at 24 hours after 10 days of daily 
alcohol administration (5 g/kg/day). 
These findings suggest that chronic 
ethanol sensitizes proinflammatory 
TLR responses that are easily observed 
after the clearance of alcohol. 
Taken together, the observations 
indicate that chronic ethanol sensitizes 
both systemic and brain responses to 
neuroimmune-gene activation through 
induction of HMGB1 and TLR 
proteins. Ethanol-induced leaky gut 
occurs after high binge-drinking 
doses, with gut ethanol exposure often 
being equivalent to the beverage 
content (i.e., 80 proof is 40 percent 
ethanol). As a result, bacterial products 
enter the circulation to the liver and 
activate liver monocytes (i.e., Kupffer 
cells), which then produce cytokines, 
including TNF-α. The TNF-α can  
be transported to the brain, activating 
brain neuroimmune signaling that 
persists for long periods (Qin et al. 
2007). Thus, at least two mechanisms 
of ethanol activation of neuroimmune 
signaling exist—a direct activation 
within the brain and the spread of a 
systemic innate immune activation  
to the brain (figure 6).
Summary
Binge drinking stimulates neuroimmune- 
gene induction, which increases 
neurodegeneration through increased 
oxidative stress, particularly NADPH 
oxidase-induced oxidative stress.  
In addition, HMGB1–TLR4 and 
NF-κB signaling are increased, leading 
to enhanced expression of NF-κB 
target genes and, ultimately, to 
persistent and sensitized neuroimmune 
responses to ethanol and other agents 
that release HMGB1 or directly stim-
ulate TLR receptors and/or NMDA 
receptors. Persistent neuroimmune- 
gene induction alters stress-coping 
mechanisms and the sympathetic 
nervous system, resulting in the HPA- 
mediated enhancement of peripheral 
cytokines, which further exacerbates 
the neuroimmune response. In addition 
to neuroimmune signaling, glutamate 
excitotoxicity also is linked to alcoholic 
neurodegeneration. 
It has been proposed that, instead  
of simply being a side effect of exces-
sive alcohol consumption, neuronal 
damage associated with drinking  
actually may underlie some of the 
mechanisms of developing alcohol use 
disorder (Crews and Boettiger 2009). 
The development of dependence is 
thought to result at least in part from 
a lack of inhibition of the subcortical 
mesolimbic reward system by the 
frontal cortex (Koob and Le Moal 
1997). Alcohol-induced cell death in 
regions such as the prefrontal cortex 
may lead to lack of inhibition in 
subcortical reward areas such as the 
striatum, which in turn may reduce 
behavioral inhibition and increase 
motivation to drink. Repeated stimu-
lation of the innate immune system 
during chronic or heavy alcohol 
consumption may facilitate this 
process, leading to decreased inhibi-
tion of the mesolimbic reward system 
and thus increased drinking (Crews et 
al. 2011). These processes may be 
particularly relevant in adolescence, 
when persistent and long-lasting 
increases in brain neuroimmune-gene 
expression and neurodegeneration 
may be associated with the develop-
ment of alcohol use disorder. 
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